For more information on Roth Capital's "China Comes to Vegas" Conference, dedicated to Chinese-based, U.S. listed companies, please visit http://www.roth.com .
For more information on Rodman & Renshaw's Annual Global Investment Conference, featuring Steel, Metals & Mining, Energy, Healthcare, Asia & Growth and SPACs Tracks, please visit http://www.rodmanandrenshaw.com/conferences .
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a biopharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost- effective, high margin business model is driven by market demand and supported by 8 scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across more than 29 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Bio-pharmaceutical Co., Ltd (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
Safe Harbor Statement
Certain statements in this press release and oral statements made by
China Pharma on its conference call in relation to this release, constitute
forward-looking statements for purposes of the safe harbor provisions under
The Private Securities Litigation Reform Act of 1995. Any statements set
forth above that are not historical facts are forward-looking statements
that involve risks and uncertainties that could caus
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved